Phytomed AG - Результати пошуку

bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - oftalmologiske - eylea er indiceret til voksne til behandling af:neovaskulær (våd) aldersrelateret macula degeneration (amd);synsnedsættelse på grund af macula ødem sekundær til retinal veneokklusion (filial rvo eller central rvo);synsnedsættelse på grund af diabetisk macula ødem (dme);synsnedsættelse på grund af nærsynet choroidal neovascularisation (nærsynet cnv).

Європейський Союз - данська - EMA (European Medicines Agency)

adempas

bayer ag - riociguat - hypertension, lunge - antihypertensive midler til pulmonal arteriel hypertension - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. effekten har været vist i en pah befolkningen, herunder aetiologies af idiopatisk eller arvelige pah eller pah, der er forbundet med bindevævssygdom. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.